Loading
A phase 1/2 trial of toripalimab in colorectal cancer, run by Dan Feng, now recruiting.
Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases is a phase 1/2, interventional study registered as NCT07277322 by Dan Feng, with a registry enrolment figure of 24 participants, started 2026-09-01 and due to reach its primary completion in 2028-12-31. Interventions recorded: Dupilumab; Toripalimab. Conditions listed: Metastatic Colorectal Cancer; Liver Metastases. Primary outcome: Number of dose limiting toxicities (DLTs). Colorectal eligibility wording from the registry: "* Has not undergone a hysterectomy or bilateral oophorectomy; or". Sites: United States. No results are recorded here; the registry entry is the source.
Shares Coherus BioSciences, Toripalimab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Coherus BioSciences, Toripalimab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Toripalimab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Toripalimab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Toripalimab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Toripalimab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Toripalimab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.